Home/ Stocks/ BNGO

Bionano Genomics, Inc. Common Stock

BNGO XNAS

$1.83 +0.13 (+7.51%) ▲ 15-min delayed

Open

$1.73

High

$1.89

Low

$1.73

Volume

978.5K

Market Cap

$20.37M

About Bionano Genomics, Inc. Common Stock

Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in the Americas, EMEA, and Asia Pacific, of which the EMEA region generates the majority of its revenue. It generates product revenue from sales of its OGM and Ionic Purification systems and consumables, which include its instruments and their VIA software.

Sector: LABORATORY ANALYTICAL INSTRUMENTS Employees: 97 Website →

Key Financials

Period	Revenue	Net Income	EPS
Q2 2026	$8.17M	$-7,423,000	$-0.64
Q1 2026	$6.69M	$-8,303,000	$-0.76
FY 2025	$28.51M	$-26,395,000	$-4.85
Q3 2025	$7.37M	$-8,503,000	$-1.59

Earnings & Analyst Ratings

Next Earnings: Wed, Nov 11, 2026

Calendar →

Related Market News

No specific coverage for BNGO yet. Check out our latest market news or earnings calendar.

Get BNGO Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Bionano Genomics, Inc. Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.